Across TCGA pan-cancer cohorts, RNA5SP513 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNA5SP513 data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNA5SP513 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP513 expression acts as an unfavorable survival marker, although some lineages such as LGG and LUSC show a favorable association.
UCS, ESCA, and BLCA are the cancer types where RNA5SP513 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.